Stay up-to-date on our latest developments
OXURION to Present at the Lytham Partners Fall 2021 Investor Conference
Leuven, BELGIUM, Boston, MA, US – 5 October, 2021 – 08.00 AM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will present at the Lytham Partners Fall 2021 Investor Conference.
- Lytham Partners Fall 2021 Investor Conference
October 5-7, 2021
Pre-recorded CEO Presentation available starting on October 5 at 10:15 AM ET
For more information, please visit Oxurion’s events page.